Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does INFLIXIMAB Cause Cardiovascular disorder? 160 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 160 reports of Cardiovascular disorder have been filed in association with INFLIXIMAB (Renflexis). This represents 0.1% of all adverse event reports for INFLIXIMAB.

160
Reports of Cardiovascular disorder with INFLIXIMAB
0.1%
of all INFLIXIMAB reports
25
Deaths
24
Hospitalizations

How Dangerous Is Cardiovascular disorder From INFLIXIMAB?

Of the 160 reports, 25 (15.6%) resulted in death, 24 (15.0%) required hospitalization, and 4 (2.5%) were considered life-threatening.

Is Cardiovascular disorder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for INFLIXIMAB. However, 160 reports have been filed with the FAERS database.

What Other Side Effects Does INFLIXIMAB Cause?

Off label use (34,801) Drug ineffective (33,738) Condition aggravated (16,616) Rheumatoid arthritis (16,251) Pain (15,061) Fatigue (13,473) Arthralgia (13,441) Infusion related reaction (12,946) Product use issue (12,752) Drug intolerance (11,173)

What Other Drugs Cause Cardiovascular disorder?

ADALIMUMAB (482) ACETAMINOPHEN\PROPOXYPHENE (453) TESTOSTERONE (434) PROPOXYPHENE (399) CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (354) CRESTOR (319) TESTOSTERONE CYPIONATE (221) LEVOFLOXACIN (213) METHOTREXATE (206) RITUXIMAB (193)

Which INFLIXIMAB Alternatives Have Lower Cardiovascular disorder Risk?

INFLIXIMAB vs INFLIXIMAB-ABDA INFLIXIMAB vs INFLIXIMAB-AXXQ INFLIXIMAB vs INFLIXIMAB-DYYB INFLIXIMAB vs INFLIXIMAB-QBTX INFLIXIMAB vs INFLIXIMAB, RECOMBINANT

Related Pages

INFLIXIMAB Full Profile All Cardiovascular disorder Reports All Drugs Causing Cardiovascular disorder INFLIXIMAB Demographics